Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.07.26
关于召开2018年第三次暂时股东大会的提醒性通告
2018.07.24
关于2018年第三次暂时股东大会现场聚会所在变换的通告
2018.07.14
关于控股子公司股权转让的希望通告
2018.07.10
第四届董事会第十五次聚会决议通告
2018.07.10
第四届监事会第十一次聚会决议通告
2018.07.10
关于全资孙公司向银行申请授信暨接受关联方担保的通告
2018.07.10
关于向建行申请内保外贷暨提供反担保的通告
2018.07.10
关于全资孙公司向银行申请授信暨公司提供担保的通告
2018.07.10
关于召开2018年第三次暂时股东大会的通知通告
2018.07.05
2018年半年度业绩预告修正通告
第一页
上一页
51
52
53
54
55
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】